交易中 11-18 10:35:03 美东时间
-0.040
-4.02%
Eli Lilly partners with Stipple Bio in a $5.9B licensing deal to develop targeted cancer treatments using its Pointillist Platform.
今天 01:18
几个月前,鲜翾博士出任同源康生物首席AI官(CAIO)。这家由港股上市公司同源康医药孵化的子公司,专注双抗、三抗、TCE与下一代ADC,还有一个更激进的标签—...
11-16 12:04
五年前,120 万元一针的 CAR-T 曾刷爆全网,「打一针卖掉一套房」一度成为 CAR-T 的代名词。 昨日,2026 年国家基本医保药品目录正式公布。药明巨...
11-15 16:14
Anthropic CEO Dario Amodei predicts AI will make major diseases obsolete within a decade. Pharma leaders and scientists aren't buying the timeline.
11-14 03:32
Source: TradePulse / Data as of 2:00PM EST Market Overview Recent aggregate flow data reflects continued participation across several key market segments, particularly technology, semiconductors, energy,
11-13 04:14
MetaVia reports positive Phase 1 data showing that once-weekly DA-1726 significantly reduces serum uric acid and liver fat.
11-13 01:40
Moderna raises its 2026 revenue forecast to 15%-25% and accelerates oncology investments, expanding its mRNA platform into new therapies.
11-12 23:01
Nkarta (NKTX) reports positive Phase 1/2 safety data for NKX019 cell therapy with zero severe immune toxicities across 5 autoimmune diseases.
11-11 23:44
Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced that it has commenced an underwritten public
11-11 05:22
PepGen reports positive Phase 2 results for PGN-EDODM1 in DM1, showing record splicing correction and notable functional improvements.
11-11 02:47